319 related articles for article (PubMed ID: 33851224)
1. [HPV vaccination and the prevention of genital warts and precancerous lesions-current evidence and evaluation].
Osmani V; Klug SJ
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 May; 64(5):590-599. PubMed ID: 33851224
[TBL] [Abstract][Full Text] [Related]
2. HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a retrospective cohort analysis.
Osmani V; Fett S; Tauscher M; Donnachie E; Schneider A; Klug SJ
BMC Cancer; 2022 Dec; 22(1):1293. PubMed ID: 36494790
[TBL] [Abstract][Full Text] [Related]
3. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
McCormack PL; Joura EA
BioDrugs; 2011 Oct; 25(5):339-43. PubMed ID: 21942919
[TBL] [Abstract][Full Text] [Related]
4. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
Drolet M; Bénard É; Pérez N; Brisson M;
Lancet; 2019 Aug; 394(10197):497-509. PubMed ID: 31255301
[TBL] [Abstract][Full Text] [Related]
5. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
Broomall EM; Reynolds SM; Jacobson RM
Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of HPV-induced diseases by prophylactic vaccination].
Wieland U; Kreuter A
Hautarzt; 2021 Feb; 72(2):106-113. PubMed ID: 33337514
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts-Another reason for HPV vaccination of boys.
Rob F; Tachezy R; Pichlík T; Rob L; Kružicová Z; Hamšíková E; Šmahelová J; Hercogová J
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27723194
[TBL] [Abstract][Full Text] [Related]
9. Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe.
Marty R; Roze S; Bresse X; Largeron N; Smith-Palmer J
BMC Cancer; 2013 Jan; 13():10. PubMed ID: 23298365
[TBL] [Abstract][Full Text] [Related]
10. Quadrivalent human papillomavirus vaccine.
Barr E; Tamms G
Clin Infect Dis; 2007 Sep; 45(5):609-7. PubMed ID: 17682997
[TBL] [Abstract][Full Text] [Related]
11. HPV vaccination in boys and men.
Stanley M
Hum Vaccin Immunother; 2014; 10(7):2109-11. PubMed ID: 25424825
[TBL] [Abstract][Full Text] [Related]
12. Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (gardasil(®)): a review of its use in the prevention of premalignant anogenital lesions, cervical and anal cancers, and genital warts.
McCormack PL
Drugs; 2014 Jul; 74(11):1253-83. PubMed ID: 25022951
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
Goldstone SE; Giuliano AR; Palefsky JM; Lazcano-Ponce E; Penny ME; Cabello RE; Moreira ED; Baraldi E; Jessen H; Ferenczy A; Kurman R; Ronnett BM; Stoler MH; Bautista O; Das R; Group T; Luxembourg A; Zhou HJ; Saah A
Lancet Infect Dis; 2022 Mar; 22(3):413-425. PubMed ID: 34780705
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus infection: Epidemiology, biology, host interactions, cancer development, prevention, and therapeutics.
Wolf J; Kist LF; Pereira SB; Quessada MA; Petek H; Pille A; Maccari JG; Mutlaq MP; Nasi LA
Rev Med Virol; 2024 May; 34(3):e2537. PubMed ID: 38666757
[TBL] [Abstract][Full Text] [Related]
15. Estimating the long-term effects of HPV vaccination in Germany.
Horn J; Damm O; Kretzschmar ME; Deleré Y; Wichmann O; Kaufmann AM; Garbe E; Krämer A; Greiner W; Mikolajczyk RT
Vaccine; 2013 May; 31(19):2372-80. PubMed ID: 23518405
[TBL] [Abstract][Full Text] [Related]
16. Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant genital lesions, genital cancer and genital warts in women.
McCormack PL; Joura EA
Drugs; 2010 Dec; 70(18):2449-74. PubMed ID: 21142263
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of genital human papillomavirus infection in a female adolescent population.
Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
[TBL] [Abstract][Full Text] [Related]
18. Nonavalent human papillomavirus vaccination as alternative treatment for genital warts.
Bossart S; Gabutti MP; Seyed Jafari SM; Hunger RE
Dermatol Ther; 2020 Jul; 33(4):e13771. PubMed ID: 32500585
[TBL] [Abstract][Full Text] [Related]
19. [Cervix carcinoma--Austrian Vaccination Committee recommends HPV vaccination].
Six L; Joura EA
Wien Med Wochenschr; 2007; 157(5-6):130-2. PubMed ID: 17427010
[No Abstract] [Full Text] [Related]
20. [AN HPV-ASSOCIATED DISEASES AND CERVICAL CANCER AND PROPHYLACTIC HUMAN PAPILLOMAVIRUS (HPV) VACCINES].
Malinova M
Akush Ginekol (Sofiia); 2015; 54 Suppl 1():25-31. PubMed ID: 26137767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
